leupeptin has been researched along with Invasiveness, Neoplasm in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lauffenburger, DA; Luo, JH; Mamoune, A; Wells, A | 1 |
| Fridman, R; Hamilton, TC; Kanemoto, T; Martin, GR | 1 |
| Ahsan, A; Ostrowski, LE; Pagast, P; Persky, B; Schultz, RM | 1 |
3 other study(ies) available for leupeptin and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Calpain-2 as a target for limiting prostate cancer invasion.
Topics: Animals; Calpain; Cell Movement; Cysteine Proteinase Inhibitors; Down-Regulation; ErbB Receptors; Glycoproteins; Humans; Leupeptins; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Oligonucleotides, Antisense; Prostatic Neoplasms; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2003 |
Effects of synthetic peptides and protease inhibitors on the interaction of a human ovarian cancer cell line (NIH:OVCAR-3) with a reconstituted basement membrane (Matrigel).
Topics: Amides; Amino Acid Sequence; Aminocaproates; Antineoplastic Agents; Benzamidines; Biocompatible Materials; Cell Adhesion; Cell Line; Chemotaxis; Collagen; Dose-Response Relationship, Drug; Drug Combinations; Female; Glycoproteins; Humans; In Vitro Techniques; Laminin; Leupeptins; Metalloendopeptidases; Molecular Sequence Data; Neoplasm Invasiveness; Oligopeptides; Ovarian Neoplasms; Pepstatins; Polyamines; Protease Inhibitors; Proteoglycans; Tissue Inhibitor of Metalloproteinases; Tumor Cells, Cultured; Tyrosine | 1991 |
Inhibition of proteolytic enzymes in the in vitro amnion model for basement membrane invasion.
Topics: Amnion; Animals; Basement Membrane; Blood Physiological Phenomena; Cathepsin B; Cathepsins; Cell Membrane; Cysteine Endopeptidases; Endopeptidases; Female; Humans; In Vitro Techniques; Leupeptins; Melanoma; Mice; Neoplasm Invasiveness; Plasminogen Activators; Pregnancy; Protease Inhibitors; Serine Endopeptidases; Urokinase-Type Plasminogen Activator | 1986 |